COVID-19: The CIDRAP Viewpoint: Report 7: Reassessing COVID-19 Vaccine Deployment in Anticipation of a US B.1.1.7 Surge: Stay the Course or Pivot?   [open pdf - 0B]

This is the seventh report from the University of Minnesota's Center for Infectious Disease Research and Policy (CIDRAP) related to the coronavirus pandemic. From the Pressing Issues: "1. The more transmissible SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] B.1.1.7 variant could lead to a significant surge in US cases in the next 4 to 12 weeks. If the B.1.1.7 surge overlaps with low vaccine coverage, it will cause immense strain on an already burdened healthcare system, threatening the level and quality of care available to all patients. 2. The immediate goal of public health agencies should be to reduce hospitalizations and deaths as well as maintain the ability of the healthcare system to provide adequate healthcare services and minimize preventable suffering and deaths. 3. Age is the strongest risk factors for severe disease, hospitalization, and death from COVID-19 [coronavirus disease 2019]. In the event of a case surge, the vast majority of hospitalizations and deaths would occur in adults 65 years and older. 4. Compared to when the mRNA [messenger ribonucleic acid] vaccines were authorized, we now have more complete data regarding the B.1.1.7 variants, including how they led to surges in other countries and their currently rapidly increasing incidence in the US. 5. We have a short period to relieve the strain on healthcare systems and save lives by strategically targeting vaccination to those at highest risk of hospitalization and death."

2021 Regents of the University of Minnesota
Retrieved From:
Center for Infectious Disease Research and Policy (CIDRAP): https://www.cidrap.umn.edu/
Media Type:
Help with citations